Central retinal thickness at 3 months after surgery; · patients undergoing cataract surgery
1 finding from 1 review
Adverse effects · patients undergoing cataract surgery
1 finding from 1 review
MO at 3 months after cataract surgery, clinically symptomatic, · patients undergoing cataract surgery
NSAIDS may leads to lower MO at 3 months after cataract surgery; clinically symptomatic compared with steroids (low certainty).
1 finding from 1 review
Mean postoperative best‐corrected visual acuity · patients undergoing cataract surgery
1 finding from 1 review
Poor vision due to MO at 12 months after surgery · patients undergoing cataract surgery
It is very uncertain whether NSAIDS plus steroids changes poor vision due to MO at 12 months after surgery compared with steroids (very low certainty).
1 finding from 1 review
Quality of life at 3 months after surgery · patients undergoing cataract surgery
1 finding from 1 review
Central retinal thickness at 3 months after surgery; · patients undergoing cataract surgery
1 finding from 1 review
Adverse effects · patients undergoing cataract surgery
1 finding from 1 review
MO at 3 months after cataract surgery, clinically symptomatic, · patients undergoing cataract surgery
NSAIDS plus steroids may leads to lower MO at 3 months after cataract surgery, clinically symptomatic, compared with steroids (low certainty).
1 finding from 1 review
Mean postoperative best‐corrected visual acuity · patients undergoing cataract surgery
1 finding from 1 review
Poor vision due to MO at 3 months after surgery · patients undergoing cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Poor vision due to MO at 12 months after surgery · patients undergoing cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants with at least 1 bleeding episode · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
It is very uncertain whether thrombopoietin mimetics changes number of participants with at least 1 bleeding episode compared with placebo or standard care (very low certainty).
1 finding from 1 review
Intervention not reported
Number of participants with severe or life‐threatening bleeding · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
It is very uncertain whether the intervention changes number of participants with severe or life‐threatening bleeding (very low certainty).
1 finding from 1 review
Intervention not reported
Number of days on which bleeding occurred ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Time from randomisation to first bleeding episode ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of platelet transfusions ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Thromboembolic events ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found